Farther Finance Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.9K | Buy |
14,202
+6,470
| +84% | +$32.7K | ﹤0.01% | 1934 |
|
|
2025
Q1 | $39.4K | Sell |
7,732
-25
| -0.3% | -$127 | ﹤0.01% | 2017 |
|
|
2024
Q4 | $52.4K | Buy |
7,757
+1,353
| +21% | +$9.15K | ﹤0.01% | 1640 |
|
|
2024
Q3 | $42.2K | Buy |
6,404
+4,091
| +177% | +$27K | ﹤0.01% | 1739 |
|
|
2024
Q2 | $17.3K | Buy |
2,313
+135
| +6% | +$1.01K | ﹤0.01% | 1831 |
|
|
2024
Q1 | $20.4K | Buy |
2,178
+2,136
| +5,086% | +$20K | ﹤0.01% | 1488 |
|
|
2023
Q4 | $414 | Buy |
+42
| New | +$414 | ﹤0.01% | 3029 |
|